‌

US Patent 7629347 Protein tyrosine kinase inhibitors

Patent 7629347 was granted and assigned to Critical Outcome Technologies, Inc. on December, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Critical Outcome Technologies, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76293470

Patent Inventor Names

Jianhua Zhong0

Natalie Lazarowych0

Martyn Brown0

Wayne R. Danter0

Stephen Houldsworth0

George Ma0

Ghenadie Rusu0

Date of Patent

December 8, 2009

Patent Application Number

105311070

Date Filed

October 9, 2003

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention relates to uses of the compounds of Formula I as well as pharmaceutically acceptable salts and stereoisomers thereof in methods to treat a variety of tumors in mammals involving abnormal tyrosine kinase signaling, the compounds represented as: